Cancer Treatments

Study reveals that ancient DNA regions are key to activating the immune system against cancer

Light scattering technique helps personalize chemotherapy treatments

Researchers have uncovered a new biomarker whose activity can be blocked to prevent graft-versus-host disease following hematopoietic stem cell transplantation

Researchers show how a new technique known as hyperpolarization can be used to monitor how effective cancer drugs are at slowing a tumor's growth

Researchers gain new insight into why patients who initially respond well to immunotherapy drugs known as checkpoint inhibitors can develop resistance to these therapies

More than 95 percent of patients eventually succumb to drug-resistant GIST, underscoring the importance of starting patients on the most effective available drug

Clinical trial of selpercatinib shows strong response for patients with non-small cell lung cancer

The analysis, done in three colon cancer cell lines, is believed to be the first to profile transcriptome-level changes in response to DNA damage across individual cells

Recent study also provides new clues on how to monitor the efficacy of therapy

UC San Diego study indicates mutant HRAS is a key, cancer-driving oncogene—and that it's a druggable target